trump glp-1 Novo, Lilly Shares Drop as Promises $150 Ozempic Trump says GLP-1 weight-loss drugs
Description
Weekly Meal Planner
GLP-1 Patch does not contain synthetic GLP-1 and is not a GLP-1 agonist drug
A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial results reported at AAIC.
TGA-issued safety alert and advertising crackdown highlights the need for GPs to help patients navigate the complicated area of weight loss.
People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical trial results from Lilly.
